Total neoadjuvant treatment with short-course radiotherapy followed by sintilimab plus capecitabine–oxaliplatin versus short-course radiotherapy followed by capecitabine–oxaliplatin in patients with locally advanced rectal cancer (SPRING-01): a single-centre, open-label, phase 2, randomised controlled trial

Feng Tian, Honghai Dai, Dan Sha, Yuanzi Yu, Haiyan Jing, Cong Sun, Liang Shang, Yubo Liu, Renxiang Feng, Jun Li, Hongjun Liu, Yuezhi Chen, Yulong Shi, Jinshen Wang, Hongqing Zhuo, Xiaoqiao Zhang, Guodong Lian, Wei Chong, Hao Chen, Zhe Yang, Leping Li, Changqing Jing